Skip to main content
Fig. 2 | Virology Journal

Fig. 2

From: Production of recombinant HPV11/16 E6/E7-MBP-His6 fusion proteins and their potential to induce cytokine secretion by immune cells in peripheral blood

Fig. 2

The impact of recombinant HPV11/16 E6/E7-MBP-His6 proteins on the cytotoxicity and cell viability of PBMCs. a The cytotoxicity of the recombinant proteins on PBMCs was evaluated using an LDH release assay. b The viability of PBMCs after the recombinant proteins treatment was detected by CCK-8 assay. Treatment with the MBP-His6 protein was used as the control. The experiments were done in triplicate, and data from representative ones were demonstrated

Back to article page